5-Methyl Folate 1000 mcg
Product analysis
5-Methyl Folate 1000 mcg supplies folate in an active form to support normal blood formation and cell division.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality100
The folate is supplied in an active form that the body can use. That supports its form quality without establishing extra benefits from a larger serving.
Ingredient Transparency80
The folate amount and named forms are disclosed. Their individual proportions are not stated, limiting a complete breakdown of the folate sources.
Value For Money100
The folate provides favorable value in an active form. The practical benefit still depends on whether additional folate is needed.
Customer Satisfaction78
Customer ratings are highly positive. The modest number of ratings makes this a less established picture than a larger review history would provide.
Product Focus75
The clearest role is supporting normal blood formation and cell division, with no established hair-growth benefit when intake is adequate. The high folate serving without vitamin B12 also deserves attention when considering the rest of your nutrient intake.
- Format
Tablet - Container
- 90 Tablet(s)
- Per serving
- $0.26
- Customer rating
- 4.9 · 234 ratings
Goals
Folate provides essential nutritional support for blood formation and one-carbon metabolism. Larger amounts do not establish greater health benefits once intake is adequate. The saved findings flag high folate without vitamin B12.
How this product is rated for Everyday Health
Ingredient fit97
Goal fit
Dose adequacy
Pathways60
Depth
Breadth
Evidence82
Evidence strength
Studied preparation
Formulation logic93
Partner coverage
Conflicts
Effective doses
Folate supports normal cell division and nutrient adequacy. Those functions do not establish an independent hair-growth effect in adults with adequate intake. The declared methylfolate form and substantial serving amount do not by themselves demonstrate better hair outcomes.
How this product is rated for Hair Health
Ingredient fit97
Goal fit
Dose adequacy
Pathways0
Depth
Breadth
Evidence68
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Folate (Glucosamine Salt, Quatrefolic (6S)-5-MTHF) | 1667 mcg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
Folate Form Hierarchy
Patented Sources & Isomeric Purity
Dose, Safety & Label Transparency50
Folate Dosage by Declared Basis
Value100
Price per Bioavailable Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Intakes of Folate, Vitamin B6, and Vitamin B12 in Relation to All-Cause and Cause-Specific Mortality: A National Population-Based Cohort.
- The responsiveness of plasma homocysteine to small increases in dietary folic acid: a primary care study.
- Associations of Serum Folate and Homocysteine Concentrations with All-Cause, Cardiovascular Disease, and Cancer Mortality in Men and Women in Korea: the Cardiovascular Disease Association Study.
- The concept of folic acid supplementation and its role in prevention of neural tube defect among pregnant women: PRISMA.
- Systematic review of adverse health outcomes associated with high serum or red blood cell folate concentrations.
- Hair Loss After Metabolic and Bariatric Surgery: a Systematic Review and Meta-analysis.
- Quantitative Analysis of Selected Circulating Hematological Biomarkers, Essential Minerals, Vitamins, and Thyroid Hormones in Females Affected by Hair Loss.
- Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer.
- Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer.
- Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden.